Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP703854.RA2OL3r2pifTMUMXIRPfA3CR0LcV95A31x3FRFHKZWVKw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP703854.RA2OL3r2pifTMUMXIRPfA3CR0LcV95A31x3FRFHKZWVKw130_assertion type Assertion NP703854.RA2OL3r2pifTMUMXIRPfA3CR0LcV95A31x3FRFHKZWVKw130_head.
- NP703854.RA2OL3r2pifTMUMXIRPfA3CR0LcV95A31x3FRFHKZWVKw130_assertion wasGeneratedBy ECO_0000203 NP703854.RA2OL3r2pifTMUMXIRPfA3CR0LcV95A31x3FRFHKZWVKw130_provenance.
- NP703854.RA2OL3r2pifTMUMXIRPfA3CR0LcV95A31x3FRFHKZWVKw130_assertion wasDerivedFrom befree-20140225 NP703854.RA2OL3r2pifTMUMXIRPfA3CR0LcV95A31x3FRFHKZWVKw130_provenance.
- NP703854.RA2OL3r2pifTMUMXIRPfA3CR0LcV95A31x3FRFHKZWVKw130_assertion SIO_000772 22333693 NP703854.RA2OL3r2pifTMUMXIRPfA3CR0LcV95A31x3FRFHKZWVKw130_provenance.
- NP703854.RA2OL3r2pifTMUMXIRPfA3CR0LcV95A31x3FRFHKZWVKw130_assertion evidence source_evidence_literature NP703854.RA2OL3r2pifTMUMXIRPfA3CR0LcV95A31x3FRFHKZWVKw130_provenance.
- NP703854.RA2OL3r2pifTMUMXIRPfA3CR0LcV95A31x3FRFHKZWVKw130_assertion description "[Using the methylation-specific PCR (MSP) analysis, the unmethylated reaction (U) is dominant in both normal cell lines and benign breast tumors (100% vs. 86.2%), whereas the methylated reaction (M) is dominant in both breast cancer cell lines and invasive breast tumors (100% vs. 57.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703854.RA2OL3r2pifTMUMXIRPfA3CR0LcV95A31x3FRFHKZWVKw130_provenance.